You are here

  • Home
  • Archive
  • Volume 28, Issue 9
  • Adjuvant Pelvic Radiation “Sandwiched” Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial

Article info

Article menu
Download PDFPDF
Uterine Cancer
Adjuvant Pelvic Radiation “Sandwiched” Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial

Authors

  • Marina Frimer Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, and Women’s Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx;Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwell Health, Zucker School of Medicine at Hofstra/Northwell, Long Island, NY; PubMed articlesGoogle scholar articles
  • Eirwen M. Miller Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, and Women’s Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx;Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Allegheny Health Network, Pittsburgh, PA; PubMed articlesGoogle scholar articles
  • Viswanathan Shankar Department of Epidemiology & Population Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY; PubMed articlesGoogle scholar articles
  • Eugenia Girda Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, and Women’s Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx;Division of Gynecologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; PubMed articlesGoogle scholar articles
  • Keyur Mehta Department of Radiation Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY; PubMed articlesGoogle scholar articles
  • Harriet O. Smith Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, and Women’s Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx; PubMed articlesGoogle scholar articles
  • Dennis Y. S. Kuo Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, and Women’s Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx; PubMed articlesGoogle scholar articles
  • Gary L. Goldberg Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, and Women’s Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx;Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwell Health, Zucker School of Medicine at Hofstra/Northwell, Long Island, NY; PubMed articlesGoogle scholar articles
  • Mark H. Einstein Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, and Women’s Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx;Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Women’s Health, Rutgers New Jersey Medical School, Newark, NJ. PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Marina Frimer, MD, Zucker School of Medicine at Hofstra/Northwell, 1554 Northern Blvd, Suite 5 Manhasset, NY 11030. E-mail: mfrimer{at}northwell.edu.

Citation

Frimer M, Miller EM, Shankar V, et al
Adjuvant Pelvic Radiation “Sandwiched” Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial
International Journal of Gynecologic Cancer 2018;28:1781-1788.

Publication history

  • Received April 5, 2018
  • First published November 1, 2018.
Online issue publication 
November 01, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2018 by IGCS and ESGO